Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of anxiolytic and sedative agents. Its structure enables effective binding to central nervous system receptors, making it valuable in creating drugs that modulate GABAergic activity. Commonly employed in the preparation of triazolopyridine derivatives with enhanced bioavailability and receptor selectivity. Also utilized in research settings for structure-activity relationship studies aimed at optimizing CNS drug candidates.